Neurocrine Biosciences, Inc. (NBIX): Among Billionaire Ken Griffin’s Midcap Stock Picks with Huge Upside Potential

Jabran Kundi

Tue, May 13, 2025, 12:48 PM 4 min read

We precocious published a database of Billionaire Ken Griffin’s 10 Midcap Stock Picks with Huge Upside Potential. In this article, we are going to instrumentality a look astatine wherever Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stands against Billionaire Ken Griffin’s different midcap banal picks with immense upside potential.

Ken Griffin, the laminitis of Citadel, is an influential albeit arguable fig successful the concern industry. Ken Griffin tasted aboriginal occurrence portion trading during his assemblage days, and it is harmless to accidental that helium has ne'er looked backmost since. Despite immense setbacks during the fiscal situation of 2008, helium utilized his skills and determination to marque a comeback wherever galore others would person simply closed the money and moved on.

The billionaire capitalist presently manages assets worthy astir $65 cardinal crossed his funds. Owing to its ample size and way grounds of success, Ken Griffin’s banal moves often marque it to the quality and are intimately followed by investors. We decided to bash the same, focusing connected Mid-cap stocks that inactive had the imaginable to crook into established giants tomorrow.

To travel up with the database of billionaire Ken Griffin’s 10 midcap banal picks with immense upside potential, we looked astatine his latest 13F holdings and, among his important holdings, lone considered stocks betwixt $10 cardinal and $40 cardinal successful marketplace cap. We past looked astatine the mean expert terms people connected Wall Street and ranked the stocks according to their upside potential.

Why are we funny successful the stocks that hedge funds heap into? The crushed is simple: our probe has shown that we tin outperform the marketplace by imitating the apical banal picks of the champion hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks each 4th and has returned 373.4% since May 2014, beating its benchmark by 218 percent points (see much details here).

A healthcare nonrecreational discussing attraction options for a diligent with a neurological disorder.

Stock Upside Potential:   45.88%

Citadel Investment Group’s Stake: $346,451,879

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) operates arsenic a developer, discoverer, and marketer of pharmaceuticals for neuroendocrine, neuropsychiatric, and neurological disorders. Its large merchandise candidates see INGREZZA, Efmody capsules, Orilissa tablets, Oriahnn capsules, ALKINDI, and CRENESSITY.

The steadfast was upgraded by RBC Capital Markets from Sector Perform to Outperform, highlighting the caller marketplace downturn arsenic an charismatic buying opportunity. However, the terms people was adjusted by RBC expert Brian Abrahams from $138 to $137, anticipating short-term fluctuations owed to the latest 4th net and semipermanent uncertainty surrounding Medicare cause terms talks.